1.Applicants wishing to seek renewal of the approval of an active substance for one or more product-types shall submit an application to the [F1competent authority] at least 550 days before the expiry of the approval. Where there are different expiry dates for different product-types, the application shall be submitted at least 550 days before the earliest expiry date.
2.When applying for the renewal of the approval of the active substance, the applicant shall submit:
(a)without prejudice to Article 21(1), all relevant data required under Article 20 that it has generated since the initial approval or, as appropriate, previous renewal; and
(b)its assessment of whether the conclusions of the initial or previous assessment of the active substance remain valid and any supporting information.
F23.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F34.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Textual Amendments
F1Words in Art. 13(1) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 74(a); 2020 c. 1, Sch. 5 para. 1(1)